Headed to ACS San Diego? Join us for Happy Hour!
← Back to glossary

Pharmacophore Modeling

Method
Method
Method

Pharmacophore modeling is a computational technique used to identify and represent the essential features of a molecule that are necessary for its biological activity. These features, known as pharmacophores, include hydrogen bond acceptors and donors, hydrophobic regions, aromatic rings, and charged groups. A pharmacophore model is a three-dimensional arrangement of these features that can interact with a specific biological target to produce a desired effect.

Importance in Computational Drug Discovery

  1. Target Identification: Pharmacophore models help identify the key interaction points between a ligand and its biological target, facilitating the understanding of the molecular basis of drug action.
  2. Virtual Screening: Pharmacophore models can be used to screen large libraries of compounds to identify potential drug candidates that possess the required pharmacophoric features.
  3. Lead Optimization: By highlighting essential features for activity, pharmacophore models aid in the optimization of lead compounds to enhance their potency and selectivity.
  4. Activity Prediction: Pharmacophore models can predict the biological activity of new compounds, reducing the need for extensive experimental testing.
  5. Mechanistic Insights: They provide insights into the molecular mechanisms underlying biological activity, aiding in rational drug design.

Key Tools

1. Pharmit: An online platform for pharmacophore modeling and virtual screening.

2. LigandScout: A software tool for creating and applying pharmacophore models.

3. MOE (Molecular Operating Environment): A comprehensive suite for molecular modeling, including pharmacophore modeling and virtual screening.

4. Discovery Studio: A software platform offering tools for pharmacophore modeling, docking, and molecular dynamics simulations.

5. DeepOrigin's Pharmacophore Modeling Tool: An integrated tool for building and applying pharmacophore models optimized for drug discovery applications.

Literature

  1. "Pharmacophore Modeling in Drug Discovery: Methodology and Current Status"
    1. Publication Date: 2021-06-29
    2. DOI: 10.18596/jotcsa.927426
    3. Summary: Reviews the methodology of pharmacophore modeling, its integration with other computational methods, and its applications in drug discovery.
  2. "Pharmacophore Modeling in Drug Discovery and Development: An Overview"
    1. Publication Date: 2007-02-28
    2. DOI: 10.2174/157340607780059521
    3. Summary: Provides a historical overview of pharmacophore modeling and discusses developments in methodologies for pharmacophore identification and their applications in drug discovery.
  3. "A Computer-Aided Drug Discovery Based Discovery of Lead-Like Compounds Against KDM5A for Cancers Using Pharmacophore Modeling and High-Throughput Virtual Screening"
    1. Publication Date: 2021-10-12
    2. DOI: 10.1002/prot.26262
    3. Summary: Identifies lead compounds for KDM5A through pharmacophore modeling and high-throughput virtual screening, with further evaluation using ADMET properties and molecular dynamics simulations.
  4. "Learning the Footprints and Fingerprints: Pharmacophore Modeling in the Discovery of Potential Drug Candidates"
    1. Publication Date: 2019-04-17
    2. Summary: Discusses the basics and classifications of pharmacophore modeling, including the Per-residue energy decomposition (PRED)-based pharmacophore model method.
  5. "The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug Discovery"
    1. Publication Date: 2018-12-08
    2. DOI: 10.2174/1381612824666180810162944
    3. Summary: Reviews successful examples of pharmacophore modeling applied in virtual screening and lead optimization, providing an overview of pharmacophore-based virtual screening.
  6. "Pharmacophore Modeling: Advances, Limitations, and Current Utility in Drug Discovery"
    1. Publication Date: 2014-11-11
    2. DOI: 10.2147/JRLCR.S46843
    3. Summary: Reviews the computational implementation of the pharmacophore concept and its common usage in drug discovery, including virtual screening, ADME-tox modeling, and target identification.
  7. "Computational Discovery of SARS-CoV-2 NSP 16 Drug Candidates Based on Pharmacophore Modeling and Molecular Dynamics Simulation"
    1. Publication Date: 2021-06-01
    2. DOI: 10.1142/s2737416521500198
    3. Summary: Uses pharmacophore-based virtual screening and molecular dynamics simulations to identify potential SARS-CoV-2 NSP 16 inhibitors.
  8. "Azolium Analogues as CDK4 Inhibitors: Pharmacophore Modeling, 3D QSAR Study and New Lead Drug Discovery"
    1. Publication Date: 2017-04-15
    2. DOI: 10.1016/J.MOLSTRUC.2016.12.106
    3. Summary: Presents ligand-based pharmacophore modeling and 3D-QSAR analyses for azolium-based CDK4 inhibitors.
  9. "The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach"
    1. Publication Date: 2021-03-04
    2. DOI: 10.3389/fcell.2021.649434
    3. Summary: Identifies novel BCR-ABL inhibitors through pharmacophore modeling and virtual screening, with in vitro validation.
  10. "Unlocking Neuraminidase Inhibitors: Insights from Natural Products through Pharmacophore Modeling, Virtual Screening, and Molecular Docking"
    1. Publication Date: 2024-11-08
    2. DOI: 10.2174/0115701808334140241107111104
    3. Summary: Identifies potential neuraminidase inhibitors from natural products using pharmacophore modeling, virtual screening, and molecular docking.